investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

BETR Therapy for Herpesvirus-Associated Tumors

Martin G Pomper

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Richard Ambinder

Johns Hopkins University

Baltimore, United States

Martin G Pomper

Johns Hopkins University

Baltimore, United States

Related projects

James C Paulson

In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Ann M Moormann

Impact of Malaria on Shaping Immunity to EBV in the Etiology of Burkitt lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Frederick Appelbaum

Adult Leukemia Research Center

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Carl F Ware

HVEM-BTLA Pathway in Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Fabiola Valvert Gamboa

Precision diagnostics for lymphoma in Guatemala

Non-Hodgkin lymphoma

Pathology

Eduardo Sotomayor

Studies on the Etiopathogenesis of T-Cell Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

James L M Ferrara

Cellular and Molecular Studies of Bone Marrow Transplant

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Corey Casper

Burkitt Lymphoma Trials Network (BLTN)

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Michael Wang

A Phase II, Multicenter, International Study of Lenalidomide and Rituximab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Non-Hodgkin Lymphoma, Transformed Large Cell Lymphoma, and Grade 3 Follicular Lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies